Human iPSC models demonstrate marked bioenergetic failures and mitochondrial dysfunction in tauopathies [49, 50] and recent proteomic studies report mitochondrial and cytoskeletal protein abundance changes in brain and CSF across multiple tauopathies [25, 51]. Here, DNM2 is linked to tauopathy.